Channing Yu
- Hematology top 1%
- Acute Myeloid Leukemia Research 3
- Genetics top 2%
- Immunology top 5%
- Physiology top 2%
- Immunology and Allergy top 5%
-
- Lung Cancer Treatments and Mutations 13
- Advanced Breast Cancer Therapies 3
-
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 5
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 4
- Genomics and Chromatin Dynamics 4
- Co-authors
- Stuart H. OrkinMitchell J. WeissYuko FujiwaraJane E. VisvaderMerlin CrossleyHaidi YangAlan CantorRichard A. Wells
- Cited by
- HematologyGeneticsImmunology
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Thoracic Oncology (4 papers)Blood (4 papers)
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Channing Yu
28 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Hematology 805
- Genetics 499
- Immunology 906
- Physiology 1.0k
- Immunology and Allergy 199
Countries citing papers authored by Channing Yu
This map shows the geographic impact of Channing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Channing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Channing Yu more than expected).
Fields of papers citing papers by Channing Yu
This network shows the impact of papers produced by Channing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Channing Yu. The network helps show where Channing Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Channing Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2021 | 20 | |
| 3 | 2020 | 13 | |
| 4 | 2020 | 16 | |
| 5 | 2019 | 31 | |
| 6 | 2019 | 119 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 13 | |
| 10 | 2018 | 1 | |
| 11 | 2017 | 0 | |
| 12 | 2017 | 7 | |
| 13 | 2016 | 0 | |
| 14 | 2005 | 204 | |
| 15 | 1999 | 300 | |
| 16 | 1997 | 288 | |
| 17 | FOG, a Multitype Zinc Finger Protein, Acts as a Cofactor for Transcription Factor GATA-1 in Erythroid and Megakaryocytic Differentiationbreakdown → | 1997 | 595 |
| 18 | 1995 | 19 | |
| 19 | 1994 | 193 | |
| 20 | 1963 | 1 |
About Channing Yu
Channing Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (5 papers), Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (4 papers), Genomics and Chromatin Dynamics (4 papers), Advanced Breast Cancer Therapies (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (805 citations), Genetics (499 citations), Immunology (906 citations), Physiology (1.0k citations) and Immunology and Allergy (199 citations). Channing Yu has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Stuart H. Orkin, Mitchell J. Weiss, Yuko Fujiwara, Jane E. Visvader, Merlin Crossley, Haidi Yang, Alan Cantor, Richard A. Wells, Daniel S. Friend and Alison A. Humbles. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Blood, Annals of Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.